BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Viragen

With global operations in the U.S. , Scotland and Sweden, Viragen is a biotechnology company specializing in the research, development and commercialization of natural and recombinant protein-based drugs designed to treat a broad range of viral and malignant diseases. These protein-based drugs include natural human alpha interferon and monoclonal antibodies. Viragen's strategy also includes the development of Avian Transgenic Technology as a biomanufacturing platform for the large-scale, cost-effective production of therapeutic proteins. Viragen is publicly traded on the American Stock Exchange (VRA). Viragen's majority-owned subsidiary, Viragen International, Inc., is publicly traded on the Over-The-Counter Bulletin Board (VGNI). Viragen currently employs 62 people with corporate facilities in Plantation, Florida (Headquarters) and research and manufacturing facilities in Edinburgh, Scotland and Umeå, Sweden.


Contact Details:
865 SW 78th Avenue, Suite 100
Plantation
FL
33324
United States of America
Tel:(954) 233-8746
Fax:(954) 233-1414
Email:dcalder@viragen.com
WWW:

www.viragen.com/




Loading...

BioNews Results for Viragen:

Viragen stock revoked
East Bay Business Journal:  Aug 28 2008 6:25PM Matching: viragen

Viragen Patents:

US Patent No.Title
7259291 Enucleation of avian eggs by gamma irradiation
6433144 Compositions of highly-purified natural mixtures of type I Interferon derived from leukocytes and methods
6350589 Compositions of highly-purified natural mixtures of type I interferon derived from leukocytes and methods
5434249 Method for modulating specific activity of inteferon alpha
4435384 Transfer factor composition and skin treatment

View more Viragen patents.

Viragen (VRA) Financial information Links from Barchart

VRA Quote from from Barchart.com
VRA Chart from from Barchart.com
VRA Profile from from Barchart.com
VRA Opinion from from Barchart.com

View more Viragen finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 816 times since April 2007, the link to the organisation's website has been followed 198 times

Recent Search Terms used to find this page: www.viragen.com | www.viragen.com | www.viragen.com | Viragen interferon 2008 | Viragen 2008 | www.viragen.com | www.viragen.com | Viragen | www.viragen.com | www.viragen.com | .

Search for more companies in Plantation

Search for more companies in FL



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Viragen
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.